NCT04489186View on ClinicalTrials.gov

Continuous Cardiorespiratory Monitoring in Cystic Fibrosis

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

December 1, 2018

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Cystic Fibrosis
Interventions
DEVICE

Wearable device

Multimodal electrocardiography (ECG), bioimpedance (bioZ) and tri-axial accelerometry (ACC) monitoring with a single wearable device (Byteflies Sensor Dot) to derive heart rate, respiratory rate and actigraphy.

Trial Locations (1)

44106

University Hospitals Cleveland Medical Center, Cleveland

All Listed Sponsors
collaborator

University Hospitals Cleveland Medical Center

OTHER

lead

Byteflies

INDUSTRY

NCT04489186 - Continuous Cardiorespiratory Monitoring in Cystic Fibrosis | Biotech Hunter | Biotech Hunter